Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 7Terminated 3Withdrawn 2Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 33Myelodysplastic Syndromes 9Recurrence 7Lymphoma, Large B-Cell, Diffuse 5Hodgkin Disease 5Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia 2Wilms Tumor 1TP53 1Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden 1Primary Malignant Neoplasm of Ovary 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Blood Stem Cell Transplantation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Malignant Solid Tumor 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid 1Hematopoietic System--Cancer 1Graft vs Host Disease 1Extranodal Extension 1Esophageal Squamous Cell Carcinoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 3fludarabine phosphate 2Polymerase Chain Reaction 2Cyclophosphamide 2Antilymphocyte Serum 2treosulfan 1thymoglobulin 1sargramostim 1eprenetapopt 1Whole-Body Irradiation 1Tacrolimus 1Standard of Care 1Pharmacogenomic Testing 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Ketamine 1Immunoenzyme Techniques 1Flow Cytometry 1Filgrastim 1Decitabine 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Carboplatin 1Busulfan 1Bronchoscopy 1Bronchoalveolar Lavage 1Blood Specimen Collection 1Biopsy 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Myeloproliferative Disorders × Decitabine × Clear all
NCT00043134 2010-04-13

Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Unknown
220 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡